Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
Dollar change
Percentage change
Index- P/E48.89 EPS (ttm)0.02 Insider Own14.40% Shs Outstand72.95M Perf Week-3.51%
Market Cap80.65M Forward P/E1.75 EPS next Y0.63 Insider Trans0.00% Shs Float62.76M Perf Month-3.51%
Income6.85M PEG1.96 EPS next Q0.02 Inst Own13.37% Short Float8.72% Perf Quarter-2.65%
Sales59.65M P/S1.35 EPS this Y33.33% Inst Trans-5.52% Short Ratio10.14 Perf Half Y-25.17%
Book/sh0.41 P/B2.70 EPS next Y425.00% ROA8.76% Short Interest5.47M Perf Year-38.55%
Cash/sh0.66 P/C1.66 EPS next 5Y25.00% ROE44.48% 52W Range1.02 - 2.09 Perf YTD-38.20%
Dividend Est.- P/FCF18.46 EPS past 5Y- ROI19.97% 52W High-47.37% Beta0.78
Dividend TTM- Quick Ratio0.97 Sales past 5Y19.48% Gross Margin62.28% 52W Low7.84% ATR (14)0.06
Dividend Ex-Date- Current Ratio1.38 EPS Y/Y TTM137.36% Oper. Margin13.52% RSI (14)45.04 Volatility3.52% 5.91%
Employees208 Debt/Eq0.89 Sales Y/Y TTM45.00% Profit Margin11.48% Recom1.00 Target Price14.00
Option/ShortYes / Yes LT Debt/Eq0.15 EPS Q/Q-15.41% Payout0.00% Rel Volume0.18 Prev Close1.09
Sales Surprise- EPS Surprise- Sales Q/Q-60.91% EarningsMay 10 BMO Avg Volume539.58K Price1.10
SMA20-4.60% SMA50-4.99% SMA200-20.84% Trades Volume96,466 Change0.92%
Date Action Analyst Rating Change Price Target Change
Jun-08-20Reiterated H.C. Wainwright Buy $3 → $11
Apr-17-17Reiterated Rodman & Renshaw Buy $4 → $5
Apr-04-16Initiated Rodman & Renshaw Buy $3.50
Apr-23-15Upgrade Jefferies Hold → Buy $2 → $2.60
Nov-12-14Reiterated R. F. Lafferty Buy $8 → $5
Jan-24-14Initiated R. F. Lafferty Buy $8
May-02-12Reiterated Oppenheimer Outperform $9 → $11
May-02-12Downgrade Canaccord Genuity Buy → Hold $8 → $8
Apr-30-12Downgrade Auriga Buy → Hold $8 → $8
Oct-13-11Initiated Morgan Joseph Hold
Jun-13-24 06:50AM
May-29-24 08:38AM
May-13-24 03:05AM
May-11-24 10:27AM
May-10-24 06:56AM
06:50AM Loading…
May-03-24 06:50AM
Mar-15-24 01:17PM
Mar-14-24 08:11AM
Mar-07-24 06:50AM
Feb-23-24 06:50AM
Dec-26-23 06:50AM
Nov-30-23 04:00AM
Nov-07-23 09:04AM
08:04AM Loading…
Nov-06-23 08:04AM
Oct-30-23 06:50AM
Oct-09-23 06:50AM
Sep-12-23 06:50AM
Sep-06-23 06:50AM
Aug-08-23 09:14AM
Aug-07-23 06:50AM
Aug-01-23 06:50AM
Jul-31-23 06:50AM
Jun-08-23 06:50AM
May-30-23 11:00AM
06:50AM Loading…
May-23-23 06:50AM
May-18-23 06:50AM
May-11-23 07:59AM
May-10-23 04:16PM
May-08-23 02:32AM
May-05-23 07:26AM
May-04-23 06:50AM
Apr-27-23 06:50AM
Mar-21-23 06:50AM
Mar-13-23 06:50AM
Feb-28-23 08:52PM
Feb-27-23 06:30AM
Feb-24-23 09:15AM
Feb-21-23 06:55AM
Jan-06-23 07:04AM
Jan-03-23 06:50AM
Dec-21-22 04:30PM
Dec-05-22 06:50AM
Dec-04-22 09:00AM
Nov-30-22 02:59PM
Nov-15-22 04:46AM
Nov-14-22 06:50AM
Nov-07-22 06:50AM
Sep-21-22 08:00AM
Sep-12-22 12:40PM
Sep-06-22 06:50AM
Aug-16-22 05:55AM
Aug-15-22 06:50AM
Aug-08-22 06:50AM
Jun-30-22 04:30PM
Jun-14-22 09:23AM
May-26-22 04:30PM
May-17-22 06:13AM
May-16-22 06:50AM
May-09-22 06:50AM
Apr-07-22 10:05AM
Apr-05-22 07:40AM
Apr-04-22 06:50AM
Apr-01-22 06:22AM
Mar-31-22 06:50AM
Mar-24-22 06:50AM
Mar-18-22 09:54AM
Mar-07-22 07:00AM
Feb-28-22 04:45AM
Feb-24-22 07:27AM
Feb-03-22 06:50AM
Dec-22-21 06:50AM
Nov-15-21 10:18AM
Nov-08-21 06:50AM
Oct-15-21 08:37AM
Oct-11-21 06:50AM
Aug-26-21 06:50AM
Aug-18-21 06:06AM
Aug-16-21 06:50AM
Aug-13-21 06:50AM
Aug-09-21 07:15AM
Aug-02-21 06:50AM
Jun-30-21 09:56AM
Jun-28-21 06:50AM
Jun-07-21 10:18PM
Jun-05-21 08:16PM
Jun-03-21 09:28AM
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bashan DrorPRESIDENT AND CEOOct 19 '23Buy1.4064,51690,484132,516Oct 20 06:50 AM